𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radiation therapy in soft-tissue lesions in histiocytosis X (Langerhans' cell histiocytosis)

✍ Scribed by Gramatovici, Razvan ;D'Angio, Giulio J.


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
341 KB
Volume
16
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Langerhans' cell histiocytosis (LCH) (previously histiocytosis X) is an infrequent disease with protean clinical manifestations and an unpredictable course. The role of radiotherapy in the soft tissue complications of LCH was evaluated in this retrospective study of 40 patients seen in two major Philadelphia institutions between 1970 and 1984. The patients were divided into two groups according to the extent of disease: unifocal versus multifocal. There was a higher rate of complete response in the unifocal form (4 of 12 patients), but this was associated with a high rate of spontaneous remissions (6 out of 12 patients). Multifocal LCH has a more aggressive course, and the major organs involved (lung, liver, and spleen) did not respond to radiotherapy. Eight patients had diabetes insipidus, and none of them responded to radiotherapy or chemotherapy. Autopsies were performed in two patients with diabetes insipidus who died of disease. There were no pathologic changes in the pituitary gland or stalk, hypothalamus, or supraoptic nuclei.


πŸ“œ SIMILAR VOLUMES


Radiation therapy in the management of l
✍ Selch, Michael T. ;Parker, Robert G. πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 572 KB

## Abstract Twenty‐two patients with Langerhans cell histiocytosis (LCH) were managed in the UCLA Department of Radiation Oncology from 1974 to 1987. Their median age was 17 years (range 1–42 years) and median followup 4.5 years (range 1–13 years). Fourteen patients had disease localized to a bone

Etoposide in the treatment of six childr
✍ Viana, Marcos Borato ;Oliveira, Benigna Maria ;Silva, Celia Maria ;Leite, Virgin πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 548 KB

Six children received etoposide as the single agent for treatment of Langerhans cell histiocytosis (LCH; histiocytosis X). Five were less than 2 years old at diagnosis. All had multiorgan involvement; one had liver and pulmonary dysfunction. Two infants also had clinical signs of immune deficiency.

β€œEtoposide in the treatment of six child
✍ Whitlock, James A. πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 89 KB

Viana et al. [I] described their experience with etoposide (VP-16) as initial therapy in the management of patients with Langerhans cell histiocytosis (LCH). However, caution should be used in advocating the use of an epipodophyllotoxin as the "drug of choice" for the treatment of this disorder. Alt

T-Lymphocytes bearing the Ξ³Ξ΄ T-cell rece
✍ Alaibac, Mauro ;Chu, Anthony C. πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 611 KB

## Abstract The aim of this study was to investigate the regional importance of Ξ³Ξ΄ T cells in cutaneous lesions of Langerhans' cell histiocytosis. Six cases of Langerhans' cell histiocytosis were investigated by immunohistochemical techniques (alkaline phosphatase‐antialkaline phosphatase complex a